Fundz

Acurx Pharmaceuticals Appoints David P. Luci as Chief Executive Officer and Robert G. Shawah as Chief Financial Officer

PUBLIC · ACXPOct 26, 2026

Position

Chief Financial Officer

Company

Acurx Pharmaceuticals

Robert G. Shawah
Staten IslandBiotechnologyTherapeuticsPharmaceuticalBiopharma

Description

Acurx Pharmaceuticals announced the appointments of David P. Luci as Chief Executive Officer and Robert G. Shawah as Chief Financial Officer

Who to call at Acurx Pharmaceuticals, and when

A new leader at Acurx Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Acurx Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acurx Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Acurx Pharmaceuticals. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acurx Pharmaceuticals

Location

Staten Island, New York, United States

About

Acurx Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. Their approach includes developing antibiotic candidates with a Gram-positive selective spectrum that blocks the active site of specific bacterial enzymes, inhibiting DNA replication. The company's R&D pipeline targets various Gram-positive bacteria such as MRSA and drug-resistant Streptococcus pneumoniae. Acurx is committed to addressing significant unmet medical needs in the antibiotic space.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acurx Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

David
Likely contact at this company
••••••••@••••••••

See David's verified email →

Sooyeon
Likely contact at this company
••••••••@••••••••

See Sooyeon's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Acurx Pharmaceuticals's next move

Learn about Strategic plan

Acurx Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.